Overview
The Hematologic Malignancies Program of the Mayo Clinic Cancer Center conducts research about cancers of the blood and bone marrow.
The Hematologic Malignancies Program has three main goals:
- Investigating the epidemiology and mechanisms of progression for hematologic malignancies
- Characterizing the cell biology and molecular nature of hematologic malignancies to identify new therapeutic targets
- Developing new therapies for hematologic malignancies
The Hematologic Malignancies Program also participates in Specialized Program of Research Excellence (SPORE) grants for lymphoma and multiple myeloma.